- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Further Study Indicated for Follicular Lymphoma Vaccine
The trial evaluates the safety and effectiveness of the MyVax(R) Personalized Immunotherapy in patients with previously untreated fNHL. The trial compares patients treated with MyVax(R) Personalized Immunotherapy to patients treated with a nonspecific immunotherapy control.
The next interim analysis of data for efficacy is now scheduled to occur in mid-2006.